glp 1 black box warning GLP-1 Drug Warnings: Thyroid Cancer Risks (2026) GLP-1 Medicines and Thyroid Cancer

Drug interactions with GLP-1 agonists are relatively uncommon, but the slowed gastric emptying can affect absorption rates of oral medications taken at the same time

Tirzepatide goes a step further by engaging both GLP-1 and GIP pathways

Usually, a high dose is given first, then a lower dose is used to keep levels up

American Journal of Physiology - Gastrointestinal and Liver Physiology, 310 (1), G26

This is a marathon, not a sprint

What is the risk of serotonin syndrome in patients taking a combination of GLP-1 (Glucagon-like peptide-1) receptor agonists, SSRIs (Selective Serotonin Reuptake Inhibitors), and ADHD (Attention Deficit Hyperactivity Disorder) medications?